Medtronic PLC

• Thermo Fisher stock fell due to profit-taking and broader healthcare sector weakness. • Investors adopted cautious postures ahead of upcoming third-quarter financial results. • Macroeconomic factors, elevated bond yields, and foreign exchange headwinds weighed on prices.

• CEO Helen Giza steps down, replaced by Shervin Korangy. • Fresenius reports annual revenue of $22.13B and net profit of $1.10B. • Technical indicators show a MACD sell signal and oversold RSI.

• Guardant Health shares dropped due to profit-taking after a multi-month rally. • Ongoing unprofitability and high valuation multiples triggered intense selling pressure. • The company reported $982.02M in annual revenue and a net profit of $-416.28M.

• Natera shares pulled back due to broad profit-taking after recent peak levels. • Elevated valuations and insider share sales fueled recent short-term selling pressure. • Core fundamentals remain strong with robust volume growth across precision medicine portfolios.

• JPMorgan included Thermo Fisher in its top monthly growth stock selections. • The company reported $44.56B in annual revenue and $6.70B in profit. • Analysts issued Buy ratings with an average price target of $657.95.

• Illumina surged due to significant price target increases from Wall Street firms. • Strong NovaSeq X placement velocity drove durable fundamental momentum and margin improvements. • Technical indicators show a MACD buy signal and an overbought Williams %R.